Cytosorbents Corp - Common Stock (CTSO)

CUSIP: 23283X206

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
63,013,241
Total 13F shares
16,439,150
Share change
-497,416
Total reported value
$20,747,017
Put/Call ratio
0%
Price per share
$1.28
Number of holders
43
Value change
-$475,512
Number of buys
9
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 23283X206?
CUSIP 23283X206 identifies CTSO - Cytosorbents Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cytosorbents Corp - Common Stock (CTSO) as of Q2 2025

As of 30 Jun 2025, Cytosorbents Corp - Common Stock (CTSO) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,439,150 shares. The largest 10 holders included AVENIR CORP, Skylands Capital, LLC, VANGUARD GROUP INC, NEUBERGER BERMAN GROUP LLC, CM Management, LLC, Sargent Investment Group, LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, CIBC Private Wealth Group LLC, and STATE STREET CORP. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.